(IN BRIEF) The University of Copenhagen, in collaboration with Rigshospitalet, has introduced a clinically validated gene-editing method to identify harmful inherited mutations that raise cancer risk. Developed at the university’s Biotech Research and Innovation Center, the CRISPR-Select technique allows scientists … Read the full press release
Posted in Denmark, Education, Healthcare, News, Pharma & Biotech, Science, Technology
Tagged BRCA2, breast cancer, BRIC, cancer diagnosis, cancer risk, CRISPR-Select, gene editing, genetic testing, genomic medicine, hereditary cancer, Maria Rossing, ovarian cancer, personalized medicine, Rigshospitalet, The Journal of Clinical Investigation, University of Copenhagen, variant classification
(IN BRIEF) A study by the University of Helsinki has uncovered why some breast cancer treatments, including immunotherapy, may not be effective for all patients. The research, focusing on the mechanical properties of tumor tissue, shows that softer tissue environments … Read the full press release
Posted in Business, Education, Financial, Finland, Healthcare, Industrial, Investment, Management, News, Science, Technology
Tagged breast cancer, cancer research, cancer treatment, Finland, global research collaboration, HUS Helsinki University Hospital, immunotherapy, Kymenlaakso Health, MD-PhD student Aino Peura, Nature Communications, personalized medicine, tissue microenvironment, tumor progression, University of Helsinki
(IN BRIEF) Fraunhofer institutes have launched the BIOSYNTH project, developing a high-throughput microchip platform that uses synthetic DNA to address the growing data storage crisis. This innovative solution promises a space-saving, low-cost, and energy-efficient alternative for mass data storage, with … Read the full press release
Posted in Business, Environment, Financial, Germany, Industrial, Investment, Management, News, Science, Technology
Tagged big data technologies, Bioinformatics, BIOSYNTH project, biotechnology, data storage solutions, Fraunhofer, Hybrotec GmbH, Infineon Technologies, mass data storage, microchip platform, personalized medicine, substance screening, sustainability, synthetic biology, synthetic DNA, X-FAB Semiconductor Foundries
(IN BRIEF) Empa researchers have developed a printable, non-swelling hydrogel made from cold-water fish gelatin, enabling the creation of 3D living skin models. Designed to replicate the full complexity of human skin, including its layered architecture and cellular composition, the … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Switzerland, Technology
Tagged 3D bioprinting, artificial skin, biointerfaces, biologically compatible materials, biomimetic membranes, biotechnology, cod gelatin, cold-water fish gelatin, customized wound dressing, electrospinning, Empa, Empa Biomimetic Membranes and Textiles, Empa Laboratory for Biointerfaces, extracellular matrix, gelatin-based material, hydrogel, immune response, Kongchang Wei, Medical Innovation, non-swelling hydrogel, personalized medicine, printable hydrogel, Regenerative medicine, skin disease research, SKINTEGRITY.CH, Swiss research, synthetic skin models, Tissue Engineering, University Medicine Zurich, wound healing
(IN BRIEF) The FORESIGHT consortium, comprising leading researchers from UMC Groningen, Amsterdam UMC, NKI/AVL, and TU/e, has launched a pioneering initiative to advance immunotherapy drug development by leveraging molecular imaging and AI technologies. With a grant of at least €9 … Read the full press release
Posted in Artificial Intelligence (AI), Business, Education, Financial, Healthcare, Industrial, Investment, Management, Netherlands, News, Science, Technology
Tagged AI, Amsterdam UMC, autoimmune, cardiovascular, clinical studies, Fons van der Sommen, FORESIGHT consortium, Guus van Dongen, Health~Holland, imaging biomarkers, immunotherapy drug development, John Haanen, Liesbeth de Vries, Life Sciences & Health, molecular imaging, neurodegenerative, NKI/AVL, nuclear imaging, oncological, optical imaging, personalized medicine, Peter de With, precision medicine, preclinical studies, Public Private Partnership, Roy van der Meel, TU/e, UMC Groningen, Willem Mulder, €18 million funding, €9 million grant
(IN BRIEF) Researchers at the Institute of Cancer Research in London have identified genetic markers that predict a significant survival benefit from combining ipatasertib with abiraterone in treating metastatic castration-resistant prostate cancer. In the phase III IPATential150 trial, patients whose … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged abiraterone, AKT inhibitor, biomarkers, clinical trial, genetic markers, Institute of Cancer Research London, ipatasertib, IPATential150 trial, metastatic castration-resistant prostate cancer mCRPC, overall survival, personalized medicine, PIK3CA/AKT1/PTEN pathway, Professor Johann de Bono, PTEN gene, Roche, sequencing techniques, synthetic lethality, targeted therapy, UK patients
(IN BRIEF) Recent studies suggest that current cardiovascular risk assessment methods may be inadequate and call for a more personalized approach. Tools like carotid ultrasound offer promising solutions for more precise evaluations, enabling targeted interventions such as aspirin therapy, which … Read the full press release
Posted in Business, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged aspirin therapy, Bayer, cardiovascular disease, cardiovascular health, Cardiovascular risk, carotid ultrasound, coronary artery calcium scoring, Dr. Michael Blaha, Dr. Ricardo Salazar, healthcare access, heart disease prevention, ischemic events, medical research, personalized medicine, risk assessment, stroke prevention, subclinical atherosclerosis, subclinical plaque
VANCOUVER, Canada, 25-2-2014 — /EuropaWire/ — The British Columbia Centre for Excellence in HIV /AIDS at St. Paul’s Hospital is pioneering new technology from PHEMI Health Systems and SAP AG (NYSE: SAP) to accelerate the treatment and improve the outcome for patients diagnosed with … Read the full press release
Posted in Business, Germany, Healthcare, Technology
Tagged Bob Elliott, Dr. Julio Montaner, Dr. Paul Terry, healthcare data warehouse, HIV/AIDS, patients diagnosed with HIV/AIDS, personalized medicine, PHEMI Health Systems, powerful Big Data technology, SAP AG, SAP Canada, SAP HANA® platform, St. Paul's Hospital, The British Columbia Centre for Excellence in HIV /AIDS
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?